Northern Trust’s GH Research GHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$460K Sell
32,685
-143
-0.4% -$2.19K ﹤0.01% 3645
2025
Q4
$417K Sell
32,828
-145
-0.4% -$1.98K ﹤0.01% 3723
2025
Q3
$472K Sell
32,973
-6,004
-15% -$84K ﹤0.01% 3664
2025
Q2
$475K Sell
38,977
-354
-0.9% -$3.88K ﹤0.01% 3665
2025
Q1
$434K Sell
39,331
-1,503
-4% -$16.8K ﹤0.01% 3632
2024
Q4
$286K Buy
40,834
+8,641
+27% +$69.5K ﹤0.01% 3865
2024
Q3
$215K Buy
+32,193
New +$330K ﹤0.01% 3865
2024
Q1
Sell
-10,138
Closed -$58.8K 4443
2023
Q4
$58.8K Buy
+10,138
New +$71.6K ﹤0.01% 4207

Other funds holding GHRS

Northern Trust's GHRS Position: Q1 2026 in Review

Northern Trust reduced its GH Research (GHRS) stake by 0.44% in Q1 2026, selling an estimated $2.19K and leaving 32,685 shares worth $460K. The position accounts for ﹤0.01% of the portfolio, ranked #3645.

Northern Trust first reported a position in GHRS in Q4 2023 and has held it in 8 quarters since. The position peaked at $475K in Q2 2025. 54 funds tracked by Wall St. Rank hold GHRS as of Q1 2026.

  • Northern Trust held 32,685 shares of GH Research worth $460K as of Q1 2026.
  • Northern Trust sold 143 GH Research shares in Q1 2026, an estimated $2.19K.
  • GH Research made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3645 holding.
  • Northern Trust first reported a position in GH Research in Q4 2023 and has held it in 8 quarters since.
  • Northern Trust's GH Research position peaked at $475K in Q2 2025.
  • 54 funds tracked by Wall St. Rank held GH Research as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.